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Abstract Protein kinase (PK) Ca and Akt/PKBK cooperate in
T cell receptor/CD28-induced T cell signaling. We here demon-
strate the recruitment of endogenous Akt1 and PKCa to lipid
rafts in CD3-stimulated T cells. Further we show that Myr-
PKCa mediates translocation of endogenous Akt1 to the plasma
membrane as well as to lipid rafts, most likely explained by the
observed complex formation of both protein kinases. In addi-
tion, in peripheral mouse T cells, the PKC inhibitor Go«6850
could partially block Akt1 activation in CD3-induced signaling,
placing PKC isotype(s) upstream of Akt1. However, T cells
derived from PKCa knockout mice were not impaired in
CD3- or phorbol ester-induced Akt1 activity. Taken together,
the results of this study give new insights into the functional link
of Akt1 and PKCa in T cell signaling, demonstrating the co-
recruitment of the two kinases and showing a novel pathway
leading to Akt1 transactivation where PKC isotype(s) are in-
volved but PKCa is not essential.
3 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The protein kinase C (PKC) and Akt (also known as PKB
or RAC-PK) families are known to act in T cell survival and
proliferation signaling, but also cell cycle progression in T cell
receptor (TCR)/CD28-stimulated T cells [1]. Among all T cell-
expressed PKC isotypes, PKCa has been shown to have cell
type-selective expression and function [2]. PKCa has been
reported to selectively activate nuclear factor UB (NF-UB)
[2^5]. Akt1 is also known to activate NF-UB [6,7]. Along
this line, PKCa and Akt1 were shown to act additively in
NF-UB [8] as well as RE/AP activation, a NF-UB-binding
site-containing region within the interleukin-2 promoter [9].
Moreover, Akt1 has been shown to provide the CD28 co-
stimulatory signal [9]. However, TCR stimulation is also
known to trigger Akt1 transactivation [10,11]. Further, co-
localization of PKCa and Akt1 has been suggested to be
crucial for NF-UB transactivation, as plasma membrane-
and lipid raft-targeted mutants of PKCa and Akt1 were ob-
served to act synergistically in NF-UB activation in unstimu-
lated cells [8]. Hence, the plasma membrane and/or lipid rafts,
dynamic assemblies of cholesterol and sphingolipids which
form microenvironments in the lipid bilayer, seem to be es-
sential compartments for the activation of PKCa and Akt1
and/or subsequent substrate phosphorylation, as previously
postulated [8].
Clustering of lipid rafts has been suggested to be important
in antigen-induced T cell activation [12], as lipid rafts cluster
at the antigen-induced immunological synapse. Several studies
proposed that the presence or absence of speci¢c signaling
proteins within lipid rafts controls lymphocyte signaling [12].
In the last 2 years the role of the T cell synapse has been more
critically evaluated [13,14], nevertheless the contents of pro-
teins in lipid rafts have been extensively studied. For PKCa,
there is clear evidence that it translocates to lipid rafts in
antigen-stimulated or CD3-ligated T cells [15]. Furthermore,
it was one of the ¢rst molecules localized in the central T cell
synapse where lipid rafts cluster [16,17]. Activation of Akt1
also involves its plasma membrane translocation [18], due to
its pleckstrin homology (PH) domain, which binds to phos-
phatidylinositol 3,4,5-trisphosphate (PIP3). Phosphatidylinosi-
tol 3-kinase (PI-3K), which generates PIP3, and several PH
domain-containing proteins, like VAV and Tec kinases, have
been identi¢ed in lipid rafts, however lipid raft recruitment of
Akt has not been reported yet. Very recently, an Akt-PH-
green £uorescent protein (GFP) construct could be observed
inside and outside the immunological synapse, due to elevated
PIP3 levels [19,20]. Hence, Akt might be a possible candidate
as the e¡ector kinase of PIP3 in T cell synapse signaling.
Here we show that endogenous PKCa and Akt1 are both
recruited to lipid rafts as well as to the plasma membrane in
CD3-ligated T cells. A novel mechanism of Akt1 membrane/
raft recruitment and hence Akt1 activation is proposed, as
PKCa is shown to be constitutively bound to Akt1 and induce
Akt1 plasma membrane/raft recruitment. Furthermore, we
present data demonstrating that PKC isotypes mediate
CD3-induced Akt1 transactivation, beside parallel Akt1 trans-
activation independently of PKC enzymatic activity. How-
ever, PKCa is shown not to be essential in Akt1 transactiva-
tion. This study con¢rms and gives new insights into
the recently observed PKCa/Akt1 connection in T cell activa-
tion.
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2. Materials and methods
2.1. Reagents and plasmids
Go«6850 and LY294002 were purchased from Alexis, Lausen, Swit-
zerland. The antibodies that recognize PKC isotypes were from Signal
Transduction Labs, Upstate Biotech and Santa Cruz, respectively,
the anti-(p)Ser473 Akt antibody, (p)Akt substrate antibody from
Cell Signaling (New England Biolabs, USA) and anti-Akt1 mono-
clonal antibody (mAb) from Signal Transduction Labs, USA. The
antibody used for immunoprecipitation of PKCa was obtained from
Santa Cruz, USA. The antibody used for stimulation of Jurkat
T cells, anti-human CD28 mAb, clone 28.2 was from Pharmingen
(San Diego, CA, USA), the CD3-speci¢c antibodies OKT3 (human)
mAb and 2C11 (mouse) mAb were a gift from A. Altman. The anti-
body used for mouse T cell stimulation, anti-mouse CD28, was ob-
tained from Pharmingen. The cDNA constructs were characterized
recently [8].
2.2. Cells and transfections
Jurkat TAg cells, stably transfected with the large T antigen, were
used for experiments with transient overexpression, E6.1 Jurkat cells
were used for experiments without overexpression, as these cells ex-
press CD28 in contrast to Jurkat TAg cells. Both cell types were
maintained in RPMI medium supplemented with 10% fetal calf serum
(Life Technologies). Transient transfection of cells was performed by
electroporation in a BTX T820 ElectroSquarePorator (ITC, Biotech,
Heidelberg, Germany) apparatus using predetermined optimal condi-
tions: 2U107 cells at 450 V/cm and ¢ve pulses of 99 ms.
2.3. Puri¢cation of CD3+ mouse T cells
Peripheral CD3þ T cells from 6^9 week old mice were isolated from
lymph nodes and spleen employing human erythrocyte lysis kit and
mouse T cell enrichment columns (both RpD Systems).
2.4. Isolation of detergent-insoluble membrane (lipid raft) fractions
6U107 Jurkat TAg cells or 3U107 Jurkat E6-1 cells per assay point
were transfected with 10^20 Wg of the various cDNA expression plas-
mids, encoding wild-type (wt) or mutant PKCa as indicated (Jurkat
TAg cells), or left untransfected (Jurkat E6-1 cells). After incubation
for 21 h the cells were stimulated with solid-phase IgG clones of CD3-
and/or CD28-speci¢c antibodies for 30 min at 37‡C or left unstimu-
lated. Subsequently cells were lysed in 1 ml of ice-cold MES bu¡er (25
mM MES pH 6.5, 5 mM NaF, 1 mM Na3VO4, 2 mM EDTA, 150
mM NaCl, 0.,5% Triton X-100, 50 Wg/ml aprotinin and leupeptin),
passing the cells 30 times through a 25G needle. Lysates were mixed
with an equal volume of 80% sucrose in MES bu¡er and overlaid with
6 ml of 30% sucrose/MES and ¢nally 3.5 ml of 5% sucrose/MES.
Samples were centrifuged at 200 000Ug for 20 h at 4‡C. Tubes were
removed to ice, and 12times 1-ml fractions were collected from the
top. Horseradish peroxidase-cholera toxin B (HRP-CTB) staining of
dot blots of each fraction revealed that fractions 4 and 5 contained
lipid rafts (not shown). Fraction 12 was also retained to represent the
Triton-soluble fraction. Lipid rafts were collected by centrifugation
and solubilized in 1Usodium dodecyl sulfate (SDS) gel loading bu¡er
(50 mM Tris^HCl pH 6.8, 2% SDS, 10% glycerol, 0.1% bromophenol
blue, 5% L-mercaptoethanol).
2.5. Cell fractionation
1U107 Jurkat TAg cells per assay point were transfected with 10 Wg
cDNA expression plasmids, encoding mutant pEFneo Myr-PKCa or
as expression control, pEFneo GFP. After incubation for 21 h cells
were stimulated with solid-phase antibodies against CD3 (Dynal IgG
beads) for 20 min at 37‡C or left unstimulated. Cell fractionation was
performed by subsequent lysis in di¡erent MES lysis bu¡ers (as de-
scribed above; without Triton, soluble fraction; containing 0.5% Tri-
ton X-100, particulate fraction; containing 2% SDS, non-soluble frac-
tion). 1U106 cell equivalents of the soluble fraction and 1U107 cell
equivalents of the particulate and the non-soluble fraction were ana-
lyzed by immunoblotting.
2.6. Co-immunoprecipitation analysis
1U107 Jurkat T cells were lysed in 1 ml lysis bu¡er (25 mM MES
pH 6.5, 5 mM NaF, 1 mM Na3VO4, 2 mM EDTA, 150 mM NaCl,
0.5% Triton X-100, 50 Wg/ml aprotinin and leupeptin). Lysates were
precleared for 30 min at 4‡C. Immunoprecipitation of PKCa was
performed at 4‡C overnight. Thereafter incubation with protein G
Sepharose (Amersham-Pharmacia, Vienna, Austria) for 1 h at 4‡C,
¢ve times washing in lysis bu¡er, SDS^PAGE and immunostaining
for Akt1 was performed.
2.7. Immunoblot analysis
SDS^PAGE (4^12%) was done under reducing conditions on Bis/
Tris-bu¡ered gels (Novex, San Diego, CA, USA). Proteins were trans-
ferred onto a polyvinylidene di£uoride membrane (Millipore, Bedford,
MA, USA) by semi-dry blotting (90 mA, 80 min, 4‡C). The primary
antibodies were diluted in Tris-bu¡ered saline containing 0.05%
Tween 20 and 5% non-fat dry milk for incubation. Peroxidase-con-
jugated antibodies (Pierce, Rockford, IL, USA) served as secondary
reagent (1:5000). For antigen detection enhanced chemiluminescence
was used (Super Signal, Pierce).
2.8. Immuno£uorescence analysis of T cells
Jurkat T cells were stimulated for 40 min with polystyrene beads
(PolySciences) coated with anti-CD3. Freshly isolated mature CD3þ
T cells were incubated with biotinylated anti-CD3 and anti-CD28
(Pharmingen, both at 10 Wg/ml) for 15 min at 4‡C. Afterwards the
cells were seeded on poly-L-lysine (Sigma)-coated glass coverslips and
incubated with streptavidin for 30 min at 37‡C. The coverslips were
washed twice with phosphate-bu¡ered saline (PBS, 4‡C) and the cells
¢xed with Fix and Perm (An der Grub Bioresearch) for 15 min at
25‡C. In a ¢rst staining step FITC-labeled CTB subunit (Sigma
C1655) diluted in PBS was added to the cells and incubated for 30
min at 25‡C. After extensive washing with PBS (six times) Akt1 goat
antibody (Santa Cruz sc-7126) diluted in permeabilization solution
(Fix and Perm) was added to the cells and incubated for 60 min at
25‡C. Followed by another washing step (6UPBS) rhodamine-conju-
gated anti-goat IgG (Rockland code 605-700-125) diluted in permea-
bilization solution was added to the cells and incubated again for 60
min at 25‡C. The coverslips were washed six times with PBS and
afterwards antifade reagent (SlowFade Light Antifade Kit, Molecular
Probes) was applied according to the manufacturer’s instructions.
Coverslips mounted on slides with Mowiol mounting solution (Cal-
biochem) were used for microscopy with an Olympus BX50 £uores-
cence microscope and acquisition of pseudoconfocal images was car-
ried out with an automated Z-axis controller (E662 LVPZT Position
Servo Controller, Visitron Systems) using the digital camera Micro-
view TE/CCD1317-K/1 (Princeton Scienti¢c Instruments) and Meta-
morph imaging 4.5 software (Universal Imaging Corporation). Finally
the pictures (except controls) were processed with the AutoDeblur 7.5
software (Autoquant Imaging) and three-dimensional reconstruction
was carried out again with the Metamorph imaging 4.5 software.
3. Results
3.1. The plasma membrane/lipid raft-targeted mutants of PKCa
(Myr-PKCa) and Akt1 (Myr-Akt) localize in lipid rafts
of unstimulated Jurkat T cells
The recently described Myr-PKCa and Myr-Akt cDNAs [8]
and as control PKCa wt and Akt1 wt cDNAs were overex-
pressed in Jurkat TAg cells. Lipid raft association was ana-
lyzed by immunoblotting of raft fractions obtained from a
sucrose gradient of Triton lysates. As shown in Fig. 1 the
myristoylated mutants of PKCa and Akt1 but not or at least
to a much lower extent the wt enzymes were constitutively
associated with lipid rafts. This is shown to be not due to
di¡erent expression levels as equal expression of wt and myr-
istoylated enzymes is demonstrated by immunoblotting of the
Triton-soluble fraction.
3.2. PKCa and Akt1 are recruited to lipid rafts of CD3-ligated
Jurkat T cells
Lipid raft isolation by sucrose gradient of Triton-solubilized
Jurkat T cells was performed. Fig. 2 shows the raft fractions
immunoblotted for PKCa and Akt1 under di¡erent stimula-
tion conditions. Cell stimulation anti-CD3 was su⁄cient to
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induce translocation of endogenous Akt1 and PKCa to the
lipid rafts (Fig. 2A) but no recruitment could be observed in
cells stimulated with CD28 alone. No recruitment could be
observed in unstimulated cells either (not shown) and CD28
co-stimulation did not enhance Akt1 or PKCa raft transloca-
tion. In addition, staining for PKCK was performed. This
isotype could not be detected in the lipid raft fractions of
stimulated cells. CD3-induced Akt1 translocation could also
be reproduced in Jurkat TAg cells, with overexpressed Akt1
and CD28 (Jurkat TAg cells do not express endogenous
CD28) (Fig. 2B). Additionally, immuno£uorescence microsco-
py was done, investigating the raft recruitment of Akt1 and as
positive control PKCa in CD3-stimulated Jurkat T cells (Fig.
3). Consistent with the subcellular fractionation data, both
PKCa and Akt1 are recruited to lipid rafts, polarized by
CD3 beads. In cells without raft polarization (cells not bound
to beads) less raft localization ( = co-localization with CTB) of
PKCa and Akt1 was detected.
3.3. Complex formation of endogenous PKCa and Akt1 in
Jurkat cells
PKCa and Akt1 physically associate in Jurkat TAg cells,
when Akt1 and CD28 are overexpressed [8]. Here we further
demonstrate the constitutive association of endogenous Akt1
and PKCa proteins by co-immunoprecipitation analysis (Fig.
4). The association was not signi¢cantly a¡ected by CD28,
CD3 or CD3/CD28 activation.
3.4. Overexpression of the plasma membrane/lipid raft-targeted
mutant of PKCa in Jurkat T cells induces translocation of
endogenous Akt1 to the plasma membrane and lipid rafts
Jurkat TAg cells, overexpressing a plasma membrane/lipid
raft-targeted PKCa mutant (Myr-PKCa), were investigated
for changes in the subcellular distribution of endogenous
Akt1. Employing cellular fractionation and lipid raft prepa-
ration by sucrose gradient, Akt1 is shown to translocate to the
particulate fraction (containing plasma membrane) (Fig.
5A,B) and to the lipid raft fraction (Fig. 5C,D) in Jurkat
TAg cells, expressing the Myr-PKCa mutant. Consistently,
phorbol ester stimulation of Jurkat cells mediated transloca-
tion of Akt1 to the plasma membrane (data not shown). Em-
ploying an antibody which recognizes phosphorylated Akt
substrates, recently described by Zhang et al. [21], we also
detected Akt substrates in the lipid raft fraction of Myr-
PKCa-expressing Jurkat cells (Fig. 5D). This Akt substrate
transphosphorylation site antibody was tested for its speci¢c-
ity by comparing it with a (p)PKC substrate antibody and a
(p)PKA substrate antibody, which recognized di¡erent phos-
phorylation patterns of cellular proteins (not shown). CD3
stimulation is shown to be more e¡ective in translocating
Akt1 to the plasma membrane (Fig. 5A,B). However, a likely
explanation may be that protein overexpression by electropo-
ration only a¡ects about 25^30% of the cells, as CD3 cell
stimulation activates all cells.
Fig. 2. Localization of PKCa and Akt1 in lipid rafts. A,B: Jurkat
TAg cells were transfected with PKCa wt, Akt1 wt cDNA and
CD28 (B), whereas for determination of endogenous PKCa and
Akt1 Jurkat T cells were left untransfected (A). The cells were
stimulated for 25 min at 37‡C with solid-phase IgG clones of CD3-
and/or CD28-speci¢c antibodies. Subsequently, lipid rafts were pre-
pared by fractionation of sucrose gradients. Lipid raft fractions
were immunostained for PKCa and Akt1. As a marker for the raft
fraction, lck was used, and GM1 of each fraction was quanti¢ed in
a dot blot employing HRP-CTB (not shown). A representative ex-
periment of two independent experiments is shown.
Fig. 1. The lipid raft/membrane-targeted mutants of PKCa (Myr-
PKCa) and Akt1 (Myr-Akt) are constitutively associated with lipid
rafts. Jurkat TAg cells were transfected with PKCa wt and Akt1 wt
or Myr-PKCa and Myr-Akt cDNA, respectively. Lipid rafts were
prepared by fractionation of sucrose gradients. Lipid raft fractions
(R) and to control for expression the detergent-soluble fraction (S)
was immunostained for PKCa. As a marker for the raft fraction, a
mAb raised against lck was used, and GM1 of each fraction was
quanti¢ed in a dot blot employing HRP-CTB (not shown). A repre-
sentative experiment of three independent experiments is shown.
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3.5. Akt1 is downstream of PKC isotypes in
CD3/CD28-induced signaling in peripheral mouse T cells
To test whether PKCa and/or other PKC family members
physiologically act upstream of Akt1 in CD3/CD28-induced
signaling, as suggested above, we looked at CD3þ peripheral
mouse T cells, as Jurkat cells reveal constitutive Akt1 activity,
due to loss of phosphoinositol phosphatase and tensin homo-
log, a phosphatase-degrading PIP3 [22]. Akt1 activity was
determined by immunostaining for Akt (Ser473) phosphory-
lation, a phosphorylation site of Akt1 known to be critical for
Akt1 kinase activity [23]. Additionally, staining for phosphor-
ylated Akt substrates [21] in whole cell lysates of mouse T
cells was performed. The most prominent CD3/CD28-induced
Akt phosphorylation was a 30 kDa protein substrate (p30),
recently identi¢ed as S6 ribosomal protein [21]. Of note, phor-
bol myristate acetate (PMA)-induced phosphorylation of p30
is dependent on PI-3K activity, as the PI-3K inhibitor
LY294002 can decrease its phosphorylation, further con¢rm-
Fig. 3. Localization of PKCa and Akt1 in polarized lipid rafts by anti-CD3 ligation (pseudoconfocal immuno£uorescence). Jurkat T cells were
stimulated for 40 min with polystyrene beads coated with anti-CD3. Akt1, PKCa and lipid raft aggregation toward beads was analyzed by sub-
sequent staining with isotype-speci¢c antibodies (Akt1 or PKCa/TRITC-conjugated anti-IgG) and FITC-conjugated CTB, respectively. A repre-
sentative aggregate is shown.
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ing the speci¢city of this Akt substrate (Fig. 6A), consistent
with a PI-3K/Akt-dependent phosphorylation [18]. The same
substrate was phosphorylated by CD3 stimulation in the ab-
sence of a CD28 stimulus (not shown). Employing both meth-
ods for determination of Akt1 activity we were able to show
that inhibition of all conventional and novel PKC subfamilies
(cPKC, nPKC) by Go«6850 (also known as GF109203X and
used at 100 nM) decreases CD3/CD28-induced Akt1 activity
((p)Ser473: V45%; (p)p30: V54%). Consistently, the phor-
bol ester PMA, an activator of the c and nPKCs, is able to
induce Akt1 activity, which can again be abolished by prein-
cubation with the PKC inhibitor Go«6850 ((p)Ser473:
V100%; (p)p30: V80%), excluding pleiotropic e¡ects of
non-PKC phorbol ester receptors, and placing c and/or
nPKC isotype(s) upstream of Akt1 (Fig. 6B,C).
Fig. 4. Complex formation of Akt1 and PKCa. Co-immunoprecipi-
tation analysis of PKCa and Akt1. Jurkat T cells were stimulated
for 20 min at 37‡C with solid-phase IgG clones of CD3- and/or
CD28-speci¢c antibodies. Afterwards, cell extracts were immunopre-
cipitated (IP) with normal goat serum (Mock) or a polyclonal anti-
PKCa antibody. The immunoblots were stained for PKCa (lower
panel) and Akt1 (upper panel). A representative experiment of three
independent experiments is shown.
Fig. 5. Translocation of Akt1 to the plasma membrane and lipid rafts by overexpression of Myr-PKCa. Jurkat TAg cells were transfected with
Myr-PKCa or GFP. After 21 h cells were stimulated with solid-phase CD3 for 20 min or left unstimulated, as indicated. A: Subcellular distri-
bution of endogenous Akt1 was determined by immunoblotting. The cell fractions are de¢ned as the soluble (s) fraction, the particulate (pt)
fraction and the Triton X-100 non-soluble (ns) fraction, which were prepared as described in Section 2. The fyn protein was detected to control
for cell fractionation. B: Statistical analysis of Akt1 recruitment to the pt fraction and to the lipid raft fraction. Mean valuesW S.E.M. of two
or three independent experiments are shown. C: Lipid rafts (R) were prepared by fractionation of sucrose gradients. As a marker for the raft
fraction, staining for lck was performed. As expression control, the detergent-soluble fraction (S) was immunostained for PKCa. D: The same
blot as in C was also stained for phosphorylated Akt substrates.
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3.6. PKCa is dispensable in CD3/CD28- or PMA-induced
Akt1 activation
To test whether PKCa is the speci¢c PKC isotype upstream
of Akt1 in the signaling cascade, we investigated T cells de-
rived from PKCa knockout mice (Pfeifhofer et al., J. Exp.
Med., submitted). However, employing the same experimental
approach as in Fig. 6, T cells de¢cient in PKCa did not reveal
any decrease in CD3/CD28- (Fig. 7A) or in PMA- (Fig. 7B)
induced Akt1 activity compared with wt mouse T cells. Addi-
tionally, we stimulated the cells with CD3 in the absence of
CD28, but no di¡erence could be observed either (data not
shown).
3.7. CD3/CD28 crosslinking induces Akt1 capping in primary
mouse T cells
Importantly, endogenous Akt also localizes the CD3/CD28
crosslinking-induced caps in primary T cells. Consistent with
the subcellular fractionation data of Jurkat cells, Akt1 (sim-
ilarly to PKCa, [15]) is recruited to lipid rafts, polarized by
CD3/CD28 crosslinking (Fig. 8). In cells without raft polar-
ization (unstimulated control) virtually no raft localization
( = co-localization with CTB) of Akt1 was detected.
4. Discussion
We here demonstrate that endogenous PKCa and Akt1 are
recruited to the plasma membrane as well as to lipid rafts in
CD3-ligated Jurkat T cells. The PH domain of Akt is known
to bind PIP3, generated by activated PI-3K. Akt1 membrane
localization was found to be a primary determinant of its
subsequent activation by PDK1, which also contains a PIP3-
binding PH domain [24]. PKCa has also been reported to
translocate by a PI-3K-dependent mechanism [25]. However,
this is the ¢rst study demonstrating recruitment of Akt1 to
lipid rafts. Several studies have suggested a role for lipid rafts
in Akt signaling. Recently, a novel, raft-associated Akt1
Ser473 kinase activity has been identi¢ed [26]. Ligation of
the T cell co-receptor molecule CD38 has also been reported
to involve lipid rafts in Akt transactivation [27]. Further, LAT
is a raft-associated transmembrane adapter molecule, which
Fig. 6. Akt1 activation is regulated by PKC isotypes in peripheral
mouse T lymphocytes. A,B: CD3þ mouse lymphocytes, puri¢ed
from lymph nodes and spleen, were treated with LY294002 (10
WM), Go«6850 (100 nM) and DMSO bu¡er control, as indicated.
Subsequently, cells were stimulated with solid phase CD3/CD28 or
PMA (30 ng/ml) for 20 min at 37‡C, or left unstimulated. Akt1 ac-
tivity was determined in an immunoblot, employing staining for
(p)Ser473 Akt and for (p)p30, recognized by a Akt substrate site-
speci¢c antibody, respectively. C: Statistical analysis of Akt1 recruit-
ment to the particulate (pt) fraction and to the lipid raft fraction.
Mean valuesW S.E.M. of two or three independent experiments are
shown.
Fig. 7. Enzymatic activity of Akt1 is equal in T lymphocytes de-
rived from PKCa-de¢cient or wt mice, stimulated with CD3/CD28
or PMA. CD3þ mouse lymphocytes, puri¢ed from lymph nodes and
spleen, were stimulated with solid phase CD3/CD28 and PMA (30
ng/ml) for 20 min at 37‡C, or left unstimulated. Akt1 activity was
determined by immunostaining for (p)Ser473 Akt and for a phos-
phorylated Akt substrate, p30, recognized by a (p)Akt substrate
site-speci¢c antibody. A representative experiment of three indepen-
dent experiments is shown.
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recruits several signaling molecules, including PKC and Akt1
activating proteins, like phospholipase CQ1 and PI-3K, upon
T cell activation. SHIP, a phosphatase of PIP3, has been de-
scribed as an inhibitor of Akt in B cells [28,29] and has also
been found to translocate to lipid rafts in inhibitory BCR
signaling [30,31]. The function of recruitment of Akt1 to lipid
rafts and the role of lipid rafts in T cell activation in general
are not clear. It has been shown that lipid rafts cluster at the
T cell synapse in antigen-induced T cells. Of note, the PH
domain of Akt has been shown to localize to the synapse in
living cells [19,20], suggesting Akt as an e¡ector kinase of
synapse signaling. Alternatively, PKCa and Akt1 additive sig-
naling could be a prerequisite for synapse formation and/or
lipid raft clustering, proposing a functional link with cytoskel-
etal reorganization. TCR-induced lipid raft clustering as well
as Akt1 activation is impaired in p110N PI-3K transgenic mice
[32]. However, in T cells derived from PKCa knockout mice,
CD3-induced lipid raft clustering seems to be normal (data
not shown). Alternatively, lipid rafts could not be essential for
T cell activation at all. Substrate phosphorylation could also
take place at the plasma membrane outside the rafts. Re-
cently, a study demonstrated that CD3-dependent TCR acti-
vation occurs independently of cholesterol extraction [33]. The
plasma membrane contains several phosphorylation PKC sub-
strates in CD3-ligated, phorbol ester-stimulated or Myr-
PKCa-expressing Jurkat T cells (B. Bauer, unpublished obser-
vation). However, a membrane-recruited mutant of PKCa
(PKCa-CAAX), which was not detectable in lipid rafts, was
not active in NF-UB signaling nor in c-Jun N-terminal kinase
2 signaling and revealed no functional synergy with Myr-Akt
(data not shown). This was not due to conformational inacti-
vation, as PKCa-CAAX revealed normal kinase activity in
vitro (data not shown). Moreover, Myr-PKCa mediated phos-
phorylation of Akt substrates in the lipid raft fraction (Fig.
5D). It is possible, therefore, that these distinct compartments,
the plasma membrane and lipid rafts, act in di¡erent signaling
cascades and biological functions but this has to be further
clari¢ed.
We here further suggest a functional link in the membrane/
raft recruitment of PKCa and Akt1. We suggest membrane/
raft recruitment of Akt1, partially independent of its PIP3-
induced membrane translocation, as also proposed for the
Akt-binding oncoprotein TCL1, which acts as an Akt co-ac-
tivator by Akt membrane recruitment [22]. We show that
PKCa is able to mediate Akt1 translocation, most probably
by complex formation. Hence, the recently observed slightly
elevated NF-UB activation induced by the Myr-PKCa mutant
[8] could be due to this translocation of endogenous Akt1.
Consistently, the signal is enhanced in cells co-expressing
both Myr-PKCa and Myr-Akt recombinant proteins. How-
ever, the Myr-Akt mutant, known to be constitutively active
[34], is inactive in NF-UB transactivation without Myr-PKCa
co-expression, indicating that PKCa has additional func-
tion(s) in NF-UB signaling than just inducing Akt1 mem-
Fig. 8. Localization of endogenous Akt1 in lipid rafts of primary CD3þ mouse T cells (pseudoconfocal immuno£uorescence). Freshly isolated
mature CD3þ mouse T cells were incubated with biotinylated anti-CD3 and anti-CD28 for 15 min at 4‡C and subsequently stimulated with
streptavidin for 30 min at 37‡C. Lipid raft fractions were immunostained employing FITC-CTB. A representative experiment is shown.
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brane/raft translocation. For instance, PKCa could mediate
recruitment of e.g. Akt1 substrates and/or e¡ectors. PKCa
has been reported to bind to the inhibitor of UB factor kinase
complex, which is also recruited to lipid rafts in CD3/CD28-
activated T cells [35].
Employing peripheral T cells this study further demon-
strates a novel, PKC-dependent transactivation pathway of
Akt1 in CD3/CD28- or only CD3-stimulated T cells. Phorbol
ester-induced Akt1 transactivation in T cells has been re-
ported previously [36] and is also demonstrated in Fig.
6B,C. In CD3-ligated naive T cells activation of c and
nPKC isotypes is upstream of Akt1 transactivation and down-
stream signaling, as a speci¢c inhibitor of c and nPKCs can
decrease Akt signaling function (Fig. 6B,C). In this PKC-in-
ducible signaling pathway leading to Akt1 transactivation, PI-
3K is involved downstream of PKC isotypes, as an inhibitor
of PI-3K can signi¢cantly albeit only partially inhibit PMA-
induced Akt1 transactivation and downstream signaling (Fig.
6A). However, PKCa is shown not to be essential employing
T cells derived from PKCa knockout mice (Fig. 7). This could
be due to functional redundancy and/or no functional require-
ment of PKCa in Akt1 transactivation. Additionally, in CD3/
CD28-ligated cells, Akt1 transactivation is mediated by a
PKC-independent pathway, seen by the only partial reduction
of Akt1 activity by the c and nPKC inhibitor Go«6850. Much
higher inhibition by Go«6850 could be achieved in PMA-in-
duced Akt1 activation (Fig. 6B,C).
In summary, this study investigates the subcellular location
of PKCa and Akt1, demonstrating their co-recruitment to the
plasma membrane including lipid rafts in CD3-activated
T cells. A novel mechanism of Akt1 membrane/raft recruit-
ment is proposed, as PKCa is shown to induce Akt1 plasma
membrane/raft recruitment, most likely explained by the ob-
served complex formation of both protein kinases. We here
further demonstrate the existence of parallel signaling path-
ways, partially regulated by c and/or nPKCs, leading to Akt1
transactivation and downstream signaling in CD3-ligated pe-
ripheral mouse T cells. PKCa is shown not to be essential for
this. This multi-regulation of Akt1 is not unexpected for this
crucial survival kinase.
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